Get the Stockscreener App
7.7101
3.20%
-0.2549
After Hours:
7.71
-0.000100
-0.00%
Moolec Science Sa stock is traded at $7.7101, with a volume of 1,617.
It is down -3.20% in the last 24 hours and up +3.21% over the past month.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
See More
Previous Close:
$7.965
Open:
$7.65
24h Volume:
1,617
Relative Volume:
0.01
Market Cap:
$5.59M
Revenue:
$7.83M
Net Income/Loss:
$-8.28M
P/E Ratio:
-0.4569
EPS:
-16.8761
Net Cash Flow:
$-6.85M
1W Performance:
-4.70%
1M Performance:
+3.21%
6M Performance:
+102.90%
1Y Performance:
-91.50%
1-Day Range:
$7.42
$8.00
1-Week Range:
$7.20
$8.41
52-Week Range:
$3.0765
$91.65
Moolec Science Sa Stock (MLEC) Company Profile
Compare MLEC vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MLEC
Moolec Science Sa
|
7.7101 | 5.42M | 7.83M | -8.28M | -6.85M | -16.88 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Moolec Science Sa Stock (MLEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-27-23 | Initiated | ROTH MKM | Buy |
Moolec Science Sa Stock (MLEC) Latest News
Why Did This Nano-Cap Food Stock More Than Double In Value Today? - Stocktwits
Enterprise value to EBITDA forward of Moolec Science SA – NASDAQ:MLEC - TradingView
Price to book forward of Moolec Science SA – NASDAQ:MLEC - TradingView
Price to earnings forward of Moolec Science SA – NASDAQ:MLEC - TradingView
Moolec Science SA Actuals & Estimates (NASDAQ:MLEC) - TradingView
Moolec Science SA (MLECW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Moolec Science SA (MLEC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Moolec Science SA (MLEC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Moolec Science SA (MLEC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Moolec Science SA (MLEC) Institutional Confidence - TradingKey
Moolec Science SA (MLECW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Moolec Science SA (MLEC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MOOLEC SCIENCE SA (MLEC) Stock Chart - ChartMill
Moolec Science SA (MLECW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Moolec Science SA (MLEC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Moolec Science SA (MLECW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Moolec Science SA (MLECW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Moolec Science SA (MLECW) Institutional Confidence - TradingKey
Moolec Science SA (MLECW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moolec Science SA (MLECW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Moolec Science SA (MLECW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Moolec Science SA (MLEC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moolec Science SA (MLEC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Moolec Science SA (MLEC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Moolec Science Warrant (MLECW) Edges Higher at $0.02, Stuck at Key LevelSector Neutral Pair - newsline.com
Moolec Science Achieves Breakthrough in Sustainable Protein Solutions - timothysykes.com
Moolec Science (MLEC) Strengthens as Shares Approach Key Resistance LevelProtective Put - newsline.com
Moolec Science Reaches Major Breakthrough in Safflower Platform - timothysykes.com
Number of shareholders of Moolec Science SA – NASDAQ:MLEC - TradingView
MLEC Q2 2025 Earnings: Narrower Loss Beats Estimates as SciTech Platform AdvancesEarnings Surprise Report - newsline.com
Number of shareholders of Moolec Science SA – NASDAQ:MLECW - TradingView
Moolec Science SA (MLEC) Q2 2025 Earnings: Narrowed Loss Surprises as Zero Revenue Path ContinuesForward EPS Estimate - newsline.com
Moolec Science Regains Nasdaq Compliance but Faces Year-Long Monitoring - TipRanks
Moolec Science (MLEC) restores Nasdaq listing compliance but faces year of monitoring - Stock Titan
Moolec Science (MLEC) Gains 4.6% as Stock Approaches Key $7.91 Resistance LevelATR Stop - thelegaladvocate.com
MLEC Q2 2025 Earnings: Narrower-than-Expected Loss as Company Advances Science PlatformProduct Revenue Analysis - thelegaladvocate.com
MLEC Q2 2025 Earnings: Narrowed Loss Beats Estimates as Operational Progress ContinuesEarnings Revision Downgrade - newsline.com
Moolec Science Warrant (MLECW) Holds at Penny Levels as Declines Exceed 5%Factor Momentum - newsline.com
Moolec Science (MLEC) Dips 2.81% as Shares Approach Key Support LevelInstitutional Sentiment - newsline.com
MLECMoolec Science SA Stock Price and Quote - Finviz
Moolec Science (MLEC) Slides 4.4% Amid Selling Pressure; Key Support at $7.06 in FocusSign of Weakness - newsline.com
MLEC Q2 2025 Earnings: Narrower Loss than Expected as Stock RisesPreliminary Results - The Legal Advocate
MLEC Q2 2025 Earnings: EPS Surprises to the Upside as Pre-Revenue Science Company Narrows LossEBITDA Margin Trends - Newser
Why Is Moolec Science S.A. (MLEC) Stock Down Today? - Meyka
MLEC Moolec EPS beats estimates but revenue plummets 285 yearoveryear shares declineSlow Growth Warning - The Legal Advocate
MSN Money - MSN
Moolec Science Shareholders Approve 2025 Accounts and Board Slate at May 13 AGM - TipRanks
Moolec Science shareholders approve financials, re-elect directors and auditor - Investing.com
[6-K] Moolec Science SA Current Report (Foreign Issuer) | MLEC SEC FilingForm 6-K - Stock Titan
Moolec Science completes 2026 safflower planting campaign By Investing.com - Investing.com South Africa
MLEC Director Core Daniel Joaquin Files Initial Ownership, May 14, 2026 - Meyka
Moolec Science Sa Stock (MLEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):